Beth E. Jackson

Beth E. Jackson, Ph.D. has a diverse work experience in the pharmaceutical and biotech industry. Beth E. currently serves as the Senior Director and Clinical Development Lead at REGENXBIO Inc. Their previous role was as a Clinical Research professional at Johnson & Johnson from 2017 to 2020. Prior to that, they worked as the Global Medical Affairs Brand Lead at Alcon in 2016 and as the Director of Medical Affairs at ThromboGenics NV from 2013 to 2016. Beth E. also held the positions of Associate Director of National Medical Affairs and Medical Science Liaison at ThromboGenics NV. Earlier in their career, Beth worked as a Medical Science Liaison at Sucampo Pharmaceuticals, Inc. in 2012 and held various roles at Alcon Laboratories, Inc. from 2007 to 2012, including Global Medical Affairs, Project Head, and Clinical Trial Manager.

Beth E. Jackson, Ph.D. completed their education from 1993 to 2004. Beth E. obtained their Bachelor of Science (B.S.) degree in Chemistry from Texas Wesleyan University between 1996 and 2000. Subsequently, they pursued further studies at Rice University and obtained their Ph.D. in Biochemistry and Cell Biology from 2000 to 2004. Prior to their university education, Beth attended Arlington High School from 1993 to 1996.